medline.ch Dermatologie Psoriasis

	Emerging Targets in Psoriatic Arthritis: Dual IL-17A/F and Selective TYK2 Inhibition in a Clinical Perspective. Mediterr J Rheumatol Dimopoulou V, Nitsa M, Koutsianas C. PMID: 41648065 [PubMed]
	Beyond Clinical Trials: Experience with Bimekizumab in 3 Challenging Cases of Psoriatic Arthritis. Mediterr J Rheumatol Papadimitriou E, Katsigianni I, Papoutsaki M, Visvikis M, Dimitroulas T, Koutsianas C, Papagoras C. PMID: 41648064 [PubMed]
	The Clinical Significance and Therapeutic Management of Dactylitis and Enthesitis in Psoriatic Arthritis. Mediterr J Rheumatol Pelechas E, Karagianni PG, Kaltsonoudis E. PMID: 41648062 [PubMed]
	The Pathophysiological Significance of Dual Inhibition of IL-17A and IL-17F in Psoriatic Arthritis and Axial Spondyloarthritis. Mediterr J Rheumatol Katsouli O, Lainis V, Goules AV, Vlachoyiannopoulos PG. PMID: 41648061 [PubMed]
	Hypoxia and oxidative stress related to inflammation andÂ vascular aspects of the pathogenesis of psoriasis. Skin Health Dis Hanssen SCA, Seyger MMB, van Erp PEJ, van der Vleuten CJM, van de Kerkhof PCM. PMID: 41646533 [PubMed]
	Off-label treatment of atopic dermatitis and psoriasis. J Dermatolog Treat Sternicka-Rohde J, Bieniaszewski L, Nowicki RJ, Purzycka-Bohdan D. PMID: 41645442 [PubMed - indexed for MEDLINE]
	Harnessing Digital Pathology Tools to Distinguish Hand Eczema From Palmar Psoriasis: A Quantitative Approach. J Cutan Pathol Sari M, Schliep S, Petzold A, Kiesewetter F, Erdmann M, Sticherling M, Berking C, Heppt MV, Koch EAT. PMID: 41645409 [PubMed - as supplied by publisher]
	Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study. J Dermatolog Treat Bonifati C, Argenziano G, Lembo S, Richetta AG, Romanelli M, Satolli F, Corazza M, Atzori L, Lasagni C, Potenza C, Savoia P, Bardazzi F, Di Lernia VG, Galluzzo M, Megna M, Giofrè C, Zichichi L, Guarneri C, Pallotta S, Fargnoli MC, Loconsole F, Offidani A, Burlando M, Piaserico S, Peris K, Papini M, Carrera CG, Prignano F, Bongiorno MR, Dapavo P, Stingeni L, Donini M, Micali G, Rongioletti F, Stinco G, Saibene F, Gramiccia T, Costanzo A. PMID: 41645401 [PubMed - indexed for MEDLINE]
	Biologic therapy is associated with reduced ocular disease in psoriasis: a real-world study. Eye (Lond) Kubovsky S, Lishinsky-Fischer N, Chowers I, Ramot Y, Levy J. PMID: 41644707 [PubMed - as supplied by publisher]
	Brief Report: A pharmacokinetic study of single-dose periungual methotrexate injections that induced multi month remission of Nail Psoriasis in five patients. J Am Acad Dermatol Mello CD, Ribeiro LF, Babadopulos T, De Nucci G, Magalhães RF. PMID: 41643748 [PubMed - as supplied by publisher]
	Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results From the SPROUT Phase 3 Trial. J Am Acad Dermatol Langley RG, Arkin L, Fiorillo L, Eichenfield LF, Lebwohl M, Strober B, Sticherling M, Swanson L, Kokolakis G, Chaudhari S, Deignan C, Zhang Z, Paller AS. PMID: 41643746 [PubMed - as supplied by publisher]
	INDIVIDUAL ARTICLE: Evidence-Based Synthesis of Deucravacitinib: Long Term Efficacy, Safety, and Practical Use in Moderate-to-Severe Psoriasis. J Drugs Dermatol Katz A, Kircik C, Lamb A, Armstrong A. PMID: 41642152 [PubMed - indexed for MEDLINE]
	ChatGPT and DeepSeek in Dermatologic Practice: Do Artificial Intelligence Models Adhere to Psoriasis Treatment Guidelines? J Drugs Dermatol Demet AN, Kaynak E, Ahmet M. PMID: 41642151 [PubMed - indexed for MEDLINE]
	Real-World Evidence of Brodalumab Effectiveness for the Treatment of Psoriasis. J Drugs Dermatol Lebwohl MG, Bhutani T, Soung J, Lain E, Jacobson A. PMID: 41642147 [PubMed - indexed for MEDLINE]
	Excimer Laser for Plaque Psoriasis: A Systematic Review and Meta-analysis. J Drugs Dermatol Gratz BW, Resnick GF, Liu T, Chung S, Stringer TP. PMID: 41642137 [PubMed - in process]
	Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab. J Drugs Dermatol Boman B, Rackham A, Cotter D. PMID: 41642132 [PubMed - indexed for MEDLINE]
	S3 Guideline for the Treatment of Psoriasis vulgaris, adapted from EuroGuiDerm - part 2: Specific clinical and comorbid situations. J Dtsch Dermatol Ges Nast A, Altenburg A, Augustin M, Bachmann F, Boehncke WH, Cornberg M, Geerdes-Fenge H, Häcker B, Härle P, Klaus J, Köhm M, Köllner A, Mrowietz U, Ockenfels HM, Pennitz A, Philipp S, Richter T, Rosenbach T, Schaberg T, Schlaeger M, Schmid-Ott G, Sebastian M, Thölken K, von Kiedrowski R, Willuhn U, Zeyen C. PMID: 41641952 [PubMed - indexed for MEDLINE]
	Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping study. J Eur Acad Dermatol Venereol Vyvey E, Soenen R, Oon HH, Mburu S, Awici-Rasmussen M, Affandi AM, Gulliver W, Choon SE, Torres T, FitzGerald A, Gonzalez-Cantero A, López-Ferrer A, Lee CH, Valenzuela F, Maul JT, Puig L, Okuse M, El-Komy M, Foley P, Vender R, Boehncke WH, Pohunek J, Wang YH, Londoño-García A, Todd G, Velasquez-Lopera M, Lebwohl M, Lau E, Schmitt-Egenolf M, Hilhorst N, Connell S, Deprez E, van Geel N, Griffiths C, Van de Kerkhof P, Lambert J. PMID: 41641893 [PubMed - as supplied by publisher]
	Phosphodiesterase 4 inhibitor combined with secukinumab relieves clinical symptoms in patients with psoriasis via regulating p38MAPK activation and the immune response inflammation. Afr Health Sci Zhang Q, Zhou Z, Zhang L, Wang X, Zhao H, Wei C, Zhao M. PMID: 41640533 [PubMed - indexed for MEDLINE]
	Global Prevalence of Obesity in Patients With Psoriatic Arthritis in the Past Four Decades: An Analysis of Trends From 1984 to 2024. Obes Rev Yu Y, Wang J, Sun X, Liu L, Wang Q, Gao P, Wang C, Li F, Li X. PMID: 41639979 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 27424

Seite 1 von 1372

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung